News

Filter

Current filters:

gabapentin

1 to 9 of 142 results

New Zealand approves proposals diazepam, gabapentin and naltrexone listing

12-07-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of proposals relating…

Asia-PacificdiazepamgabapentinGenericsnaltrexoneNeurologicalPharmaceuticalRegulation

FDA should not approve paroxetine or gabapentin for hot flashes, says Public Citizen

05-03-2013

A drug approved to treat depression and other mental health disorders and another designed to prevent…

DepomedgabapentinHisamitsu PharmaNorth AmericaparoxetinePharmaceuticalRegulationWomen's Health

Depomed shares plummet as Ph III Serada trial fails one endpoint

17-10-2011

Shares of US specialty drugmaker Depomed (Nasdaq: DEPO) fell 28.2% to $4.52 last Friday, after the company…

DepomedgabapentinNeurologicalPharmaceuticalResearchSerada

GlaxoSmithKline and XenoPort’s migraine prophylaxis drug fails in Ph II testing, sending latter’s share plunging

08-07-2010

UK drug giant GlaxoSmithKline says that its GSK1838262/XP13512 (gabapentin enacarbil), which is under…

gabapentinGlaxoSmithKlineNeurologicalPharmaceuticalResearchXenoPort

Japanese filing of gabapentin enacarbil for RLS triggers $5 million milestone from Astellas to XenoPort

20-11-2009

Japanese drug major Astellas Pharma has filed a New Drug Application with the Pharmaceuticals and Medical…

Asia-PacificAstellas PharmagabapentinLicensingNeurologicalNeurontinPharmaceutical

1 to 9 of 142 results

COMPANY SPOTLIGHT

Menarini

Back to top